Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chinook Therapeutics Inc (NQ: KDNY ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Chinook Therapeutics Inc < Previous 1 2 3 4 Next > Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm August 11, 2023 From Bragar Eagel & Squire Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 August 08, 2023 Via Benzinga Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm August 06, 2023 From Bragar Eagel & Squire Via GlobeNewswire Chinook Therapeutics Inc. (NASDAQ: KDNY) Highlighted for Surprising Price Action August 01, 2023 Via Investor Brand Network Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023 August 01, 2023 Via Benzinga Expert Ratings for Chinook Therapeutics August 01, 2023 Via Benzinga Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm July 31, 2023 From Bragar Eagel & Squire Via GlobeNewswire Chinook Therapeutics Inc. (NASDAQ: KDNY) Near the Top of Equities by Percentage Gain on 6/12 June 12, 2023 Via Investor Brand Network Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm July 26, 2023 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm July 21, 2023 From Bragar Eagel & Squire Via GlobeNewswire CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY July 21, 2023 From Kahn Swick & Foti, LLC Via Business Wire Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm July 16, 2023 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm July 10, 2023 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm July 05, 2023 From Bragar Eagel & Squire Via GlobeNewswire Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire July 05, 2023 Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis. Via Investor's Business Daily Bragar Eagel & Squire, P.C. Is Investigating Chinook, DLocal, Comerica, and Advanced Auto Parts and Encourages Investors to Contact the Firm June 30, 2023 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Bowlero, Integra, Chinook, and DLocal and Encourages Investors to Contact the Firm June 24, 2023 From Bragar Eagel & Squire Via GlobeNewswire Why Shares of Vera Therapeutics Jumped Tuesday June 20, 2023 The company announced early phase 2 trials information regarding its lead therapy. Via The Motley Fool 2 Surging Healthcare Stocks With More Fuel in the Tank June 20, 2023 These stocks climbed 74% and 78% over the past month and there could be more gains ahead. Via The Motley Fool Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm June 19, 2023 From Bragar Eagel & Squire Via GlobeNewswire Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review June 16, 2023 Stocks kept powering higher despite, but the Nasdaq is looking extended. Via Investor's Business Daily BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NexTier Oilfield Solutions Inc. (NYSE – NEX), Chinook Therapeutics, Inc. (Nasdaq – KDNY), Franchise Group, Inc. (Nasdaq – FRG), Greenhill & Co., Inc. (NYSE – GHL) June 15, 2023 From Brodsky & Smith LLC Via GlobeNewswire Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, and DZS and Encourages Investors to Contact the Firm June 14, 2023 From Bragar Eagel & Squire Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 June 14, 2023 Via Benzinga CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY June 13, 2023 From Kahn Swick & Foti, LLC Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023 June 13, 2023 Via Benzinga Novartis Stock Screams Value After Chinook Therapeutics Buyout June 13, 2023 Following a buyout of Chinook Therapeutics, Novartis slipped less than 1%. This speaks to the growth potential of Chinook and ongoing value of Novartis stock. Via MarketBeat KDNY Stock Alert: Why Short Seller Muddy Waters Is Betting Against Chinook June 12, 2023 Chinook Therapeutics is about to be acquired by Novartis. News of this deal hasn't stopped Muddy Waters from betting against KDNY stock. Via InvestorPlace Nasdaq Gains 1%; US Budget Deficit Widens In May June 12, 2023 U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.19% to 33,939.74 while the NASDAQ rose 1% to 13,391.54. The S&P 500,... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 12, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.